CytomX Therapeutics
CTMX
2,12 €
Share price
0.81%
Change (1 day)
78.09%
Change (1 year)
Categories
CytomX Therapeutics (CTMX) - Total debt
Total debt on the balance sheet as of March 2025 : €6.91 Million
According to CytomX Therapeutics 's latest financial reports the company's total debt is €6.91 Million. A company’s total debt is the sum of all current and non-current debts.
CytomX Therapeutics - Total debt on balance sheet (from 2014 to 2025)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-12-31 | €9.01 M | -28.65% |
| 2023-12-31 | €12.64 M | -24.91% |
| 2022-12-31 | €16.83 M | -12.04% |
| 2021-12-31 | €19.13 M | -5.35% |
| 2020-12-31 | €20.21 M | -18.17% |
| 2019-12-31 | €24.71 M | |
| 2018-12-31 | N/A | |
| 2014-12-31 | €2.45 M | -19.3% |
| 2013-12-31 | €3.04 M |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | €2.72 M | -60.57% | 🇺🇸 USA |